Skip to main navigation Skip to search Skip to main content

Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma

  • Su Jin Jang
  • , Joo Hyun Kang
  • , Kwang Il Kim
  • , Tae Sup Lee
  • , Yong Jin Lee
  • , Kyo Chul Lee
  • , Kwang Sun Woo
  • , Wee Sup Chung
  • , Hee Chung Kwon
  • , Chun Jeih Ryu
  • , Tae Hyun Choi
  • , Chang Woon Choi
  • , Sang Moo Lim
  • , Gi Jeong Cheon
  • Korea Institute of Radiological and Medical Sciences
  • Sejong University

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Lentiviral vector containing the HSV1-tk and firefly luciferase (fLuc) gene was infected into C6 and C6-TL expressing HSV1-tk and fLuc gene was generated. C6-TL showed higher [125I]IVDU uptake than C6. The survival rate of C6-TL decreased more rapidly with increasing GCV dose and was well correlated with fLuc activity. The images of microPET clearly demonstrated higher uptake of [18F]FHBG into the C6-TL tumor. Inhibition of tumor growth was observed in C6-TL tumor-bearing mice treated with GCV through tumor size measurement and bioluminescence imaging. The therapeutic effect of HSV1-tk/GCV system can be monitored using bioluminescent imaging and tumor size measurement.

Original languageEnglish
Pages (from-to)84-90
Number of pages7
JournalCancer Letters
Volume297
Issue number1
DOIs
StatePublished - Nov 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Glioma
  • HSV1-tk
  • Luciferase
  • Molecular imaging
  • Suicidal gene therapy

Fingerprint

Dive into the research topics of 'Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma'. Together they form a unique fingerprint.

Cite this